Enovis falls after reiterating Q1 revenue forecast, new CEO appointment

** Medical device maker Enovis Corp ENOV down 4% at $35.76

** ENOV reiterates Q1 revenue forecast to be in the range of $555 million to $563 million vs analysts' estimate of $559.6 million, according to data compiled by LSEG

** Brokerage Evercore ISI analyst Vijay Kumar says shares are down partly because co reiterated Q1 forecast but did not mention forecast for the year

** Separately, ENOV appoints Damien McDonald as chief executive officer effective May 12, 2025

** CEO Matt Trerotola previously said in February his intention to retire

** Co says Trerotola will not stand for re-election

** Stock has fallen 18.6% YTD